South African study transforms global TB treatment

Tuberculosis remains a critical public health issue in many countries and is a leading cause of death in South Africa.

Over the past six years, the BEAT Tuberculosis study, conducted in South Africa and focused on children and pregnant women, has revealed a promising new oral treatment that could mark a significant breakthrough in the fight against drug-resistant TB. Zaheer Cassim reports..